Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-9-22
|
pubmed:abstractText |
We determined the effect of 13 days of treatment with 2.0 mg/kg haloperidol, 30.0 mg/kg metoclopramide or 4.0 mg/kg domperidone on the number of tumor cells of mice bearing Ehrlich ascites carcinoma. The three dopaminergic blockers significantly reduced the number of tumor cells of experimental mice. The mean +/- SEM number of tumor cells x 10(6)/ml saline lavage was 25.5 +/- 5.9 for the haloperidol group, 36.8 +/- 4.7 for the metoclopramide group, 25.3 +/- 3.5 for the domperidone group and 54.0 +/- 9.0 for the control mice (treated with 0.9% NaCl). In a second experiment, treatment with 0.5 and 2.0 mg/kg haloperidol showed that the antitumor effect of this drug was dose dependent. The possible mechanisms underlying these results (such as an increase in prolactin levels or a direct action of these drugs on lymphocytes) are discussed in light of the specific pharmacological properties of each dopaminergic blocker.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0100-879X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
611-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1823279-Analysis of Variance,
pubmed-meshheading:1823279-Animals,
pubmed-meshheading:1823279-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1823279-Carcinoma, Ehrlich Tumor,
pubmed-meshheading:1823279-Domperidone,
pubmed-meshheading:1823279-Dose-Response Relationship, Drug,
pubmed-meshheading:1823279-Drug Screening Assays, Antitumor,
pubmed-meshheading:1823279-Haloperidol,
pubmed-meshheading:1823279-Metoclopramide,
pubmed-meshheading:1823279-Mice
|
pubmed:year |
1991
|
pubmed:articleTitle |
Antitumor effects of dopaminergic blockers in mice bearing Ehrlich tumors.
|
pubmed:affiliation |
Departamento de Farmacologia, Escola Paulista de Medicina, São Paulo, Brasil.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|